Personalized Medicines

Personalized medicines are a new therapeutic option that takes into account the genetics and individuality of patients diseases, and then develops or prescribes drug that are likely to have the most...

Antibiotic Resistance

Antimicrobial resistance (AMR) is resistance of a microorganism to an antimicrobial medicine to which it was previously sensitive. Resistant organisms (they include bacteria, viruses and some parasi...

Irritable Bowel Syndrome IBS

Irritable bowel syndrome (IBS) is a common but poorly understood chronic (long-term) condition where the normal functions of the bowel are disrupted. Symptoms of IBS include abdominal pain or discom...

Novartis

Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals,...

Drug Development for Rare Diseases

The economics of any industry relies on a large demand for a particular product; this applies to the pharmaceutical industry where efforts are focused on big and relatively straight-forward diseases...

France to suspend Bayer's Diane 35 for acne

The ANSM, the French medicines regulator, is planning to suspend the marketing authorisation for Diane 35 (cyproterone acetate plus ethinylestradiol), which is registered as an acne treatment in Franc...

France launching regulatory process for off-label use

France is implementing a regulatory process to temporarily authorize the use of selected drugs in off-label indications, according to a paper published in The New England Journal of Medicine by member...

French medicines regulator takes Bayer acne drug Diane-35 off market

Following a recent investigation (The Pharma Letter January 29), the French medicines agency (ANSM) announced yesterday its plan to suspend the marketing authorization for German drug major Bayer's (B...

News and press releases: European Medicines Agency reiterates PRAC recommendation for Diane 35 and generics

Following the conclusion of the Pharmacovigilance Risk Assessment Committee (PRAC) that the benefits of Diane 35 and its generics outweigh the risks in a specific patient group, the French National Ag...

Cytori (CYTX), Investigator-Sponsored Cell Therapy Clinical Study

      For Scleroderma Initiated in France …   A CYTX investigator-sponsored and funded clinical study evaluated Cytori’s cell therapy as a potential treatment for limited and diffu...

EMA Begins Safety Review Of Acne Drug Diane 35

A safety review of the acne drug Diane 35 (cyproterone acetate 2 mg, ethinylestradiol 35µg) and its generics has officially begun. The review was started by The European Medicines Agency's (EMA) Ph...

France suspends sales of Bayer's acne pill Diane 35 after deaths

PARIS, Jan 30 (Reuters) - France's health regulator ANSM said on Wednesday it would suspend sales of Bayer acne pill Diane 35 and its generic versions, all also used as a contraceptive, after four de...

Diane-35 Acne Drug Linked To Deaths, France Investigates

ANSM, France's health regulator, has started an inquiry into Diane-35, an acne medication which is also a contraceptive, after four people died over the last 25-year period. The deaths have been linke...

Patient's Medicine Cabinet Composition Study of 207 Families in France.

France is the first country in Europe for medicines' consumption. It is not possible to imagine a house without a medicine cabinet. There are very few data on this subject. The aim of our work was to...

Attractiveness of France for International Clinical Trials in 2012: 6(th) Survey Assessed by Leem (French Association of Pharmaceutical Companies).

Since 2002, the Leem (French Association of Pharmaceutical Companies) has conducted a survey every two years to update the attractiveness of France for international clinical trials. Thirty compa...

Prescription of Psychotropic Medicines to Pregnant Women in Nord-Pas-de-Calais, France.

Aim. Prescription of psychotropic medicines carries risks to pregnancy. It is therefore appropriate to measure the prescription rate of these compounds in pregnant women. Method. We studied the prescr...

An analysis of China's national essential medicines policy.

Although China embraced the concept of essential medicines in 1979 and issued its first National Essential Medicines List in 1982, until recently China has lacked a comprehensive national essential dr...

The fuzzy line between needs, coverage, and excess in the Mexican Formulary List: an example of qualitative market width analysis.

PURPOSE: To assess the rationality of the Mexican Formulary List (MEX-LIST). METHODS: MEX-LIST was compared with the World Health Organization Essential Medicines List (WHO-LIST) to identify drugs cla...